Experienced in Osteosarcoma

Dr. Karen H. Albritton

Pediatrics | Internal Medicine
Texas Health Resources
Cook Children's Medical Center-Dept Of Hematology & Oncology
1500 Cooper St, 5th Fl, 
Fort Worth, TX 
On Staff At

Experienced in Osteosarcoma
Texas Health Resources
Cook Children's Medical Center-Dept Of Hematology & Oncology
1500 Cooper St, 5th Fl, 
Fort Worth, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Karen Albritton is a Pediatrics specialist and an Internal Medicine provider in Fort Worth, Texas. Dr. Albritton is rated as an Experienced provider by MediFind in the treatment of Osteosarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, Osteosarcoma, and Acute Lymphoblastic Leukemia (ALL).

Her clinical research consists of co-authoring 23 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article and participated in 1 clinical trial in the study of Osteosarcoma.

Graduate Institution
UT Health Science Center At San Antonio - GME (1992)
Residency
University of North Carolina - Chapel Hill/Res OBGYN (2000)
Specialties
Pediatrics
Internal Medicine
Licenses
Internal Medicine in MA
Hospital Affiliations
Texas Health Fort Worth
Languages Spoken
English
French
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cook Children's Health Plan
  • MANAGED MEDICAID PLAN
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 6 Less Insurance Carriers -

Locations

Cook Children's Medical Center-Dept of Hematology & Oncology
1500 Cooper St, 5th Fl, Fort Worth, TX 76104
Call: 682-885-7379

Additional Areas of Focus

Dr. Albritton has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Drug, Procedure
Study Drugs: Vincristine, Dactinomycin, Cyclophosphamide, Bevacizumab, Sorafenib, Myeloid growth factor, Irinotecan, Ifosfamide, Etoposide, Etoposide phosphate, Doxorubicin, Dexrazoxane, ^1^1C-methionine
Study Phase: Phase 2
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
Enrollment Status: Active_not_recruiting
Publish Date: December 08, 2025
Intervention Type: Drug
Study Drugs: Ramucirumab, Cyclophosphamide, Vinorelbine
Study Phase: Phase 1/Phase 2
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drugs: Doxorubicin, Ifosfamide, Pazopanib
Study Phase: Phase 2/Phase 3
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Drug, Procedure, Biological, Radiation
Study Drugs: Cyclophosphamide, Doxorubicin, Doxorubicin Hydrochloride, Etoposide, Etoposide Phosphate, Ganitumab, Ifosfamide, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Brentuximab, Ipilimumab, Nivolumab
Study Phase: Phase 1/Phase 2
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Drug, Behavioral, Other, Procedure
Study Drug: 6-Mercaptopurine
Study Phase: Phase 3
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
Enrollment Status: Terminated
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drugs: Ramucirumab, Gemcitabine, Docetaxel
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

23 Total Publications

Disparities in cardiovascular disease burden among Black and Hispanic survivors of adolescent and young adult (AYA) cancer.
Disparities in cardiovascular disease burden among Black and Hispanic survivors of adolescent and young adult (AYA) cancer.
Journal: Cardio-oncology (London, England)
Published: September 24, 2025
View All 23 Publications
Similar Doctors
Distinguished in Osteosarcoma
Dr. Avanthi T. Shah
Pediatrics
Distinguished in Osteosarcoma
Dr. Avanthi T. Shah
Pediatrics

UT Southwestern - Pediatric Hematology-Oncology

5323 Harry Hines Blvd, 
Dallas, TX 
 (29.7 miles away)
214-648-3896
Languages Spoken:
English
See accepted insurances

Avanthi Shah is a Pediatrics provider in Dallas, Texas. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Osteosarcoma. Her top areas of expertise are Osteosarcoma, Hepatoblastoma, Neuroblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.

Maurizio L. Ghisoli
Distinguished in Osteosarcoma
Dr. Maurizio L. Ghisoli
Pediatrics
Distinguished in Osteosarcoma
Dr. Maurizio L. Ghisoli
Pediatrics

Texas Oncology, P.A.

7777 Forest Lane, Suite D400, 
Dallas, TX 
 (35.2 miles away)
972-566-3000
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Offers Telehealth

Maurizio Ghisoli is a Pediatrics provider in Dallas, Texas. Dr. Ghisoli is rated as an Advanced provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, Beta Thalassemia, and Bone Marrow Aspiration.

Stanton C. Goldman
Advanced in Osteosarcoma
Dr. Stanton C. Goldman
Pediatrics
Advanced in Osteosarcoma
Dr. Stanton C. Goldman
Pediatrics

Texas Oncology, P.A.

7777 Forest Lane, Suite D400, 
Dallas, TX 
 (35.2 miles away)
972-566-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stanton Goldman is a Pediatrics provider in Dallas, Texas. Dr. Goldman is rated as an Advanced provider by MediFind in the treatment of Osteosarcoma. His top areas of expertise are Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Bone Marrow Aspiration, and Bone Marrow Transplant.

VIEW MORE OSTEOSARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Albritton's expertise for a condition
ConditionClose
        • Experienced
        • Acute Lymphoblastic Leukemia (ALL)
          Dr. Albritton is
          Experienced
          . Learn about Acute Lymphoblastic Leukemia (ALL).
          See more Acute Lymphoblastic Leukemia (ALL) experts
        • Adult Soft Tissue Sarcoma
          Dr. Albritton is
          Experienced
          . Learn about Adult Soft Tissue Sarcoma.
          See more Adult Soft Tissue Sarcoma experts
        • Classical Hodgkin Lymphoma
          Dr. Albritton is
          Experienced
          . Learn about Classical Hodgkin Lymphoma.
          See more Classical Hodgkin Lymphoma experts
        • Ewing Sarcoma
          Dr. Albritton is
          Experienced
          . Learn about Ewing Sarcoma.
          See more Ewing Sarcoma experts
        • Hodgkin Lymphoma
          Dr. Albritton is
          Experienced
          . Learn about Hodgkin Lymphoma.
          See more Hodgkin Lymphoma experts
        • Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
          Dr. Albritton is
          Experienced
          . Learn about Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
          See more Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) experts
        View All 8 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          Once you submit your request, MediFind will reach out to the provider’s office to help schedule your appointment. Note that this is not a confirmed booking. You’ll receive a status update via email within 1–2 business days.

          Patient Details

          This information is for the patient who will be seen at the appointment.

              Close

              Returning patient? Use your address on file with the provider.

              Insurance Details

              Please provide information of the primary insurance holder as the practice may require this information to schedule.

              Insurance Provider *
              Insurance ProviderClose

              Appointments Details

              Let’s get more information about your appointment.

                      0 / 1000
                      By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.